The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)

Impact of neoadjuvant HER2-directed therapy on HER2 status in breast cancer.

Nicholas  Manguso

No Relationships to Disclose

Jeffrey  Johnson

No Relationships to Disclose

Reva Kakkar  Basho

No Relationships to Disclose

Heather L.  McArthur

Consulting or Advisory Role - Calithera Biosciences; Celgene; Merck; OBI Pharma; Roche; Spectrum Pharmaceuticals; Syndax

Speakers' Bureau - OBI Pharma

Research Funding - Bristol-Myers Squibb (Inst); Lilly (Inst); MedImmune (Inst); Merck (Inst); ZIOPHARM Oncology (Inst)

Travel, Accommodations, Expenses - Calithera Biosciences; Merck; OBI Pharma; Roche; Spectrum Pharmaceuticals

Hisashi  Tanaka

No Relationships to Disclose

Armando E.  Giuliano

No Relationships to Disclose